The pharmaceutical group reviews the organization of production. The reason for the cuts is the merger of two production units
Thursday 01/09/16 – RSI News
Roche, the Swiss pharmaceutical company, is reviewing the organization of its production at its headquarters in Basel: in the next two years will come 190 jobs lost; 130 by the end of 2016 and the other 60 in 2017. The reason for the cuts is the merger of two production units: the active ingredients sector and that of small molecular medicines. The note sent by the pharmaceutical giant states that the decision on the number of layoffs is not yet final.
Despite this reorganisation, the Basel site remains the most important of the group, which has a total of 9,000 employees.
ATS/CaL
